Skip to main content
Top
Published in: Digestive Diseases and Sciences 3/2024

28-01-2024 | Proctitis | MUSE:IBD

What’s UP with Ulcerative Proctitis?: It’s Not Always What You Think

Authors: Gabrielle Ritaccio, Millie D. Long, Animesh Jain, Hans H. Herfarth, Edward L. Barnes

Published in: Digestive Diseases and Sciences | Issue 3/2024

Login to get access

Excerpt

A 27-year-old man was referred to the University of North Carolina Multidisciplinary IBD clinic for evaluation of ulcerative proctitis. He was initially evaluated by his gastroenterologist for a three-month history of pain with defecation, hematochezia, constipation, and the sensation of incomplete evacuation. Symptoms progressed to having five bowel movements daily characterized by small-volume stools with mucus as well as frank bleeding. He had lost over ten pounds during this time period. He denied fevers, joint pains, or oral ulcers. He reported one male sexual partner and receptive anal intercourse. Recent testing was negative for HIV, syphilis, and gonorrhea. He denied any known infections among himself or his contacts. He reported cigarette use but denied significant alcohol use or use of recreational drugs. He described regular NSAID use. Colonoscopy revealed moderate-to-severe inflammation in the rectum with ulceration. The remainder of the exam, including evaluation of the terminal ileum, appeared normal. Biopsies of the rectum showed moderate acute and chronic proctitis. Ileal biopsies were negative for inflammation. There was no pathological evidence of infection or dysplasia. He was subsequently started on prednisone for ulcerative colitis limited to the rectum, which worsened his symptoms. He was thus referred to the University of North Carolina Multidisciplinary IBD clinic for further evaluation. …
Literature
2.
go back to reference Ceovic R, Gulin SJ. Lymphogranuloma venereum: diagnostic and treatment challenges. Infect Drug Resist. 2015;27:39–47.CrossRef Ceovic R, Gulin SJ. Lymphogranuloma venereum: diagnostic and treatment challenges. Infect Drug Resist. 2015;27:39–47.CrossRef
3.
go back to reference Stoner BP, Cohen SE. Lymphogranuloma Venereum 2015: Clinical Presentation, Diagnosis, and Treatment. Clin Infect Dis. 2015;61:S865–S873.CrossRefPubMed Stoner BP, Cohen SE. Lymphogranuloma Venereum 2015: Clinical Presentation, Diagnosis, and Treatment. Clin Infect Dis. 2015;61:S865–S873.CrossRefPubMed
5.
go back to reference Tarín-Vicente EJ, Alemany A, Agud-Dios M, et al. Clinical presentation and virological assessment of confirmed human monkeypox virus cases in Spain: a prospective observational cohort study [published correction appears in Lancet. 2022 Dec 10;400(10368):2048]. Lancet. 2022;400:661–669. Tarín-Vicente EJ, Alemany A, Agud-Dios M, et al. Clinical presentation and virological assessment of confirmed human monkeypox virus cases in Spain: a prospective observational cohort study [published correction appears in Lancet. 2022 Dec 10;400(10368):2048]. Lancet. 2022;400:661–669.
Metadata
Title
What’s UP with Ulcerative Proctitis?: It’s Not Always What You Think
Authors
Gabrielle Ritaccio
Millie D. Long
Animesh Jain
Hans H. Herfarth
Edward L. Barnes
Publication date
28-01-2024
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 3/2024
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-023-08266-9

Other articles of this Issue 3/2024

Digestive Diseases and Sciences 3/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine